|
Summary Information: Vallon Pharmaceuticals Inc. Common Stock NASDAQ:VLON |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Vallon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The Company’s lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the treatment of ADHD and narcolepsy.
__The following are links to various summary and news pages for __Vallon Pharmaceuticals Inc. Common Stock [ VLON ]. __Note: Some Links might not have information for the company. |
|